Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News US Stem Cell Inc USRM

Healthcare Biotechnology
U.S. Stem Cell, Inc. is a biotechnology company. The Company is focused on the discovery, development and subject to regulatory approval and commercialization of autologous cell therapies for the treatment of chronic and acute heart damage. The Company's product candidates are MyoCell, MyoCell SDF-1 and Adipocell. MyoCell and MyoCell SDF-1 product candidates are clinical therapies designed to... see more

Recent & Breaking News (GREY:USRM)

Stem Cells Shows Promise For Repairing Torn Meniscus

PR Newswire July 10, 2018

'Renewing Our Heroes' to Provide USRM Stem Cell Protocol to First Responders

PR Newswire June 5, 2018

USRM Chief Science Officer to Present at Fifth Annual Cell Surgical World Conference

PR Newswire June 1, 2018

USRM Chief Scientist Talks Stem Cell Journey, Autologous Stem Cells with 'Something Significant' Happy Living Podcast

PR Newswire May 17, 2018

World Bodybuilding Expert Interviews USRM Chief Science Officer At Paleo F(X) Conference

PR Newswire May 15, 2018

Autologous Stem Cell Therapy May Hold Key to Regeneration

PR Newswire May 14, 2018

USRM Chief Science Officer, Dr. Kristin Comella, Featured on Health Boot Camps' Webinar

PR Newswire May 10, 2018

U.S. Department of Justice Files Lawsuit at Request of FDA to Stop U.S. Stem Cell Clinic from Performing Autologous Stem Cell Procedure

PR Newswire May 9, 2018

U.S. Stem Cell Reports First Quarter Results

PR Newswire May 9, 2018

USRM Chief Science Officer to Host Webinar on Autologous Stem Cell Therapy

PR Newswire May 8, 2018

USRM Chief Science Officer Featured in Live Interview for Biohacker Summit in Helsinki

PR Newswire May 3, 2018

Market Demand for Stem Cell Treatments Driving Steady Increase in USRM Sales

PR Newswire April 24, 2018

USRM Announces 2017 Financial Results

PR Newswire April 16, 2018

Newest Clinic Opens Today at The Villages in Central Florida

PR Newswire April 9, 2018

USRM Demonstrates 99% Reduction in Severity of Psoriasis Utilizing Autologous Stem Cells

PR Newswire March 21, 2018

USRM Chief Science Officer to Present at Paleo f(x) Ancestral Healing Conference in Austin, Texas

PR Newswire March 20, 2018

USRM Chief Science Officer to Present at Academy of Regenerative Practices Conference

PR Newswire February 28, 2018

USRM Posts Live Webinar with World Renowned Biohacker

PR Newswire February 20, 2018

USRM Successfully Launches Stem Cell Webinar Series

PR Newswire February 12, 2018

USRM Seeing Explosive Increase in Demand for Stem Cell Therapy

PR Newswire February 6, 2018